Sixty-three patients with advanced EGFR-mutant lung cancer at 7 Canadian centers, who were being screened for the ASTRIS trial (ClinicalTrials.gov identifier: NCT02474355), participated in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback